Effect [qlco]
serum lipid [lbpr]
Profile [lbpr]
treatment [ftcn]
Dyslipoproteinemia [patf]
Patients [podg]
Continuous [idcn]
Ambulatory [ftcn]
Peritoneal Dialysis [topp]
Background [cnce]
Dyslipoproteinemia [patf]
Risk factor [qnco]
Cardiovascular disease [dsyn]
Patients [podg]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Lovastatin [orch, phsu]
Coenzyme A [bacs, nnon]
Reductase [aapp, enzy]
Inhibitor [qlco]
treating [topp]
{Non-patient} [clna]
Hypercholesterolaemia [dsyn]
Aims [idcn]
Conduct [inbe]
Single-Blind Study [resa]
cross over [genf]
placebo [topp]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Patients [podg]
Effect [qlco]
Lovastatin [orch, phsu]
mg% [qnco]
serum lipid [lbpr]
Profile [lbpr]
Safety [hcpp]
Patients [podg]
Methods [inpr]
treatment [ftcn]
Phases [tmco]
Eight [qnco]
weeks [tmco]
Duration [tmco]
Four [qnco]
weeks [tmco]
measurements [ftcn]
Make [ftcn]
serum cholesterol [lbpr]
Triglyceride [bacs, lipd]
Cholesterol, HDL [bacs, lipd]
Cholesterol, LDL [bacs, strd]
Cholesterol, VLDL [bacs, strd]
Apolipoprotein B [aapp, bacs]
Lipoprotein (a) [aapp, bacs]
Eight [qnco]
weeks [tmco]
Lovastatin [orch, phsu]
Reduced [qlco]
Total Cholesterol [lbpr]
Mean [qnco]
mmol/L [qnco]
Cholesterol, LDL [bacs, strd]
mmol/L [qnco]
Apo-B [aapp, bacs]
mg dl [qnco]
P NOS [aapp, imft]
Cholesterol, HDL [bacs, lipd]
Increased [qnco]
mmol/L [qnco]
Eight [qnco]
weeks [tmco]
therapy [ftcn]
P NOS [aapp, imft]
Triglyceride [bacs, lipd]
Decreased [qnco]
mmol/L [qnco]
Lipid [lipd]
Profile [lbpr]
placebo [topp]
Drug [phsu]
adverse effects [ftcn]
Drug [phsu]
Note [clna]
treatment [ftcn]
Liver function [ortf]
muscle enzyme [lbpr]
Not [ftcn]
Altered [ftcn]
Drug Therapy [topp]
placebo [topp]
Result [ftcn]
Lovastatin [orch, phsu]
APPEAR [qlco]
To [qlco]
Drug [phsu]
treating [topp]
Dyslipoproteinemia [patf]
Peritoneal Dialysis, Continuous Ambulatory [topp]
Patients [podg]
